In a recent development, the Indian pharmaceutical company Emcure once again requested a federal judge to dismiss a $950 million lawsuit connected to accusations of theft of trade secrets from a small-scale company based in Washington. The firm argued that it does not operate any business in Washington state or within U.S. borders, contesting the jurisdictional basis for the case.
This is the second time Emcure is seeking to have the case dismissed on largely similar grounds, raising questions about the direction the lawsuit is taking. However, the facts remain scant as the case unfolds.
Legal professionals watching for updates on this case can find additional details as they’re posted on the original article.